HUT73845A - Alkoxy-substituted beta-carbolines acting on the ampa-receptor, process for producing them and pharmaceutical compositions - Google Patents

Alkoxy-substituted beta-carbolines acting on the ampa-receptor, process for producing them and pharmaceutical compositions Download PDF

Info

Publication number
HUT73845A
HUT73845A HU9600505A HU9600505A HUT73845A HU T73845 A HUT73845 A HU T73845A HU 9600505 A HU9600505 A HU 9600505A HU 9600505 A HU9600505 A HU 9600505A HU T73845 A HUT73845 A HU T73845A
Authority
HU
Hungary
Prior art keywords
alkyl
formula
alkoxy
carboline
phenyl
Prior art date
Application number
HU9600505A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9600505D0 (en
Inventor
Dieter Seidelmann
Lechoslaw Turski
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of HU9600505D0 publication Critical patent/HU9600505D0/hu
Publication of HUT73845A publication Critical patent/HUT73845A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU9600505A 1993-08-31 1994-08-29 Alkoxy-substituted beta-carbolines acting on the ampa-receptor, process for producing them and pharmaceutical compositions HUT73845A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4330175A DE4330175A1 (de) 1993-08-31 1993-08-31 Alkoxy-substituierte beta-Carboline

Publications (2)

Publication Number Publication Date
HU9600505D0 HU9600505D0 (en) 1996-04-29
HUT73845A true HUT73845A (en) 1996-09-30

Family

ID=6497015

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9600505A HUT73845A (en) 1993-08-31 1994-08-29 Alkoxy-substituted beta-carbolines acting on the ampa-receptor, process for producing them and pharmaceutical compositions

Country Status (17)

Country Link
EP (1) EP0716657A1 (ja)
JP (1) JPH09501938A (ja)
KR (1) KR960704888A (ja)
CN (1) CN1129938A (ja)
AU (1) AU7530394A (ja)
CA (1) CA2170615A1 (ja)
CZ (1) CZ50596A3 (ja)
DE (1) DE4330175A1 (ja)
FI (1) FI960940A0 (ja)
HU (1) HUT73845A (ja)
IL (1) IL110745A0 (ja)
NO (1) NO960812L (ja)
NZ (1) NZ271615A (ja)
PL (1) PL313230A1 (ja)
SK (1) SK23896A3 (ja)
WO (1) WO1995006647A1 (ja)
ZA (1) ZA946670B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY125942A (en) 1999-09-07 2006-09-29 Upjohn Co Aminoalkoxy carbazoles for the treatment of cns diseases
IL283725B2 (en) 2017-06-20 2024-04-01 Imbria Pharmaceuticals Inc Compositions and methods for increasing efficiency of cardiac metabolism
EP3866794B1 (en) 2018-10-17 2024-12-04 Imbria Pharmaceuticals, Inc. Methods of treating rheumatic diseases using trimetazidine-based compounds
EP3976101A4 (en) 2019-05-31 2023-06-21 Imbria Pharmaceuticals, Inc. FIBROSIS TREATMENT METHODS USING COMPOUNDS THAT PROMOTE GLUCOSE OXIDATION
US11780811B2 (en) 2020-06-30 2023-10-10 Imbria Pharmaceuticals, Inc. Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11530184B2 (en) 2020-06-30 2022-12-20 Imbria Pharmaceuticals, Inc. Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11883396B2 (en) 2021-05-03 2024-01-30 Imbria Pharmaceuticals, Inc. Methods of treating kidney conditions using modified forms of trimetazidine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57123180A (en) * 1980-12-17 1982-07-31 Schering Ag 3-substituted beta-carboline, manufacture and psychotropic drug containing same
DE3545776A1 (de) * 1985-12-20 1987-06-25 Schering Ag 5-aminoalkyl-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel
DE3608089A1 (de) * 1986-03-08 1987-09-10 Schering Ag Heteroaryl-oxy-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel
AU619203B2 (en) * 1987-08-28 1992-01-23 Schering Aktiengesellschaft Isoxazole-beta-carboline derivatives
DE3943225A1 (de) * 1989-12-23 1991-06-27 Schering Ag Neue ss-carboline, verfahren zu deren herstellung und deren verwendung in arzneimitteln
US5350750A (en) * 1991-04-27 1994-09-27 Schering Aktiengesellschaft β-carboline-3-hydroxyalkylcarboxylic acid ester derivatives, process for their production and their use in pharmaceutical agents
DE4118741A1 (de) * 1991-06-05 1992-12-10 Schering Ag Neue hetaryloxy-(beta)-carboline, deren herstellung und verwendung in arzneimitteln
DE4120109A1 (de) * 1991-06-15 1992-12-17 Schering Ag 3-aryl- oder 3-hetaryl-(beta)-carboline, deren herstellung und verwendung in arzneimitteln
DE4130933A1 (de) * 1991-09-13 1993-03-18 Schering Ag Neue (beta)-carbolinderivate, deren herstellung und verwendung in arzneimitteln
DE4212529A1 (de) * 1992-04-10 1993-10-14 Schering Ag Verwendung von µ-Carbolinen als nicht-kompetitive Glutamat-Antagonisten

Also Published As

Publication number Publication date
NO960812D0 (no) 1996-02-28
FI960940L (fi) 1996-02-28
EP0716657A1 (de) 1996-06-19
NZ271615A (en) 1996-09-25
IL110745A0 (en) 1994-11-11
CZ50596A3 (en) 1996-06-12
NO960812L (no) 1996-02-28
CA2170615A1 (en) 1995-03-09
WO1995006647A1 (de) 1995-03-09
FI960940A7 (fi) 1996-02-28
PL313230A1 (en) 1996-06-10
FI960940A0 (fi) 1996-02-28
KR960704888A (ko) 1996-10-09
JPH09501938A (ja) 1997-02-25
SK23896A3 (en) 1996-11-06
CN1129938A (zh) 1996-08-28
HU9600505D0 (en) 1996-04-29
DE4330175A1 (de) 1995-03-02
ZA946670B (en) 1995-04-21
AU7530394A (en) 1995-03-22

Similar Documents

Publication Publication Date Title
US7557112B2 (en) Aromatic-ring-fused pyrimidine derivative
US20090069340A1 (en) Pyrazolone Compounds As Metabotropic Glutamate Receptor Agonists For The Treatment Of Neurological And Psychiatric Disorders
US7947690B2 (en) Pyrimidine derivative condensed with a non-aromatic ring
EP0040639B1 (en) Isoxazole derivatives
EP0378255B1 (en) 2-Aminopyrimidinone derivatives
US5496833A (en) Piperidine tachykinin receptor antagonists
US7816376B2 (en) Cyclic amides
HU214032B (en) Process for producing benzoisothiazole and benzoisoxazole-3-carboxamide derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUP0203431A2 (hu) Új heterociklusos vegyületek és sóik, és ezeket tartalmazó gyógyszerkészítmények, valamint felhasználásuk
HU211705A9 (en) Piperidine compounds, their preparation and use
JPH01249769A (ja) 向精神性ヘテロビシクロアルキルピペラジン誘導体
JP3018619B2 (ja) ６，７−ジヒドロ−３−フェニル−１，２−ベンズイソオキサゾール−４（５ｈ）−オンおよびオール、その製法およびそれを含有する医薬
US4780466A (en) Arylpiperazinylalkoxy derivatives of cyclic imides
HU206341B (en) Process for producing 3-piperazinyl-benzazol derivatives and pharmaceutical compositions containing them as active components
JPH11199573A (ja) ５ｈｔ３受容体作動薬及び新規ベンゾチアゾール誘導体
HUT73845A (en) Alkoxy-substituted beta-carbolines acting on the ampa-receptor, process for producing them and pharmaceutical compositions
AU642570B2 (en) New benzisoxazole and benzisothiazole compounds, process for the preparation thereof, and pharmaceutical compositions containing them
HK122995A (en) Indan derivatives
KR20010076389A (ko) 벤젠술폰아미드 화합물, 이의 제조 방법 및 이를 함유하는약제 조성물
HU191076B (en) Process for producing 6-fluoro/-3-(-1-heterocyclo-)-propyl/- 1,2-benzisoxazol derivatives and phrmaceiutical compositions containing them
EP0364091B1 (en) Antipsychotic 4-(4-(3-benzisothiazolyl)-1-piperazinyl)butyl bridged bicyclic imides
US5643784A (en) Indan derivatives
JP2724396B2 (ja) 骨粗鬆症予防治療剤
CN101151247A (zh) 作为肾素抑制剂的3,4,5-取代哌啶

Legal Events

Date Code Title Description
DFC4 Cancellation of temporary protection due to refusal